CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes [Phase 3]
Summary
Phase 3 clinical trial comparing NN5401 with biphasic insulin aspart 30 in type 2 diabetes completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-20